Support our work
DONATE NOW

Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)

E-session 475 / CME accredited Add to My Agenda

Expert:

Umberto Ricardi, expert of session 'Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)'

Umberto Ricardi
University of Turin
Turin, Italy

Expert:

Astrid Pavlovsky, expert of session 'Debate: should be  RT still part of treatment for Hodgkin lymphoma? (Part II)'

Astrid Pavlovsky
Clinical Research Center - FUNDALEU
Buenos Aires, Argentina

Discussant: Stefano Vagge, Radiation Oncologist
San Martino Hospital - National Cancer Institute, Genoa, Italy


The live session starts in about 5 days

Access to the live session will open 10 minutes before the start of the session



Share on:
Save to my calendar:

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

28
Mar 2019
18:15-19:00 CET

The live session starts in about 5 days
Top